Magazine Article | January 9, 2018

Not a Bad Year, After All

Perhaps the greatest heights of the biopharma sector will never be seen again — but don’t overlook the good ti mes now. Th at is the central message in the following interview with Peter Meath, who heads the Life Science Group at J.P. Morgan’s Commercial Banking business. Meath also comments on the current industry environment and offers seasoned advice to novice entrepreneurs for turning a company’s novel science into a viable business.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.